William C. Weldon

2023-10-30T11:45:35-05:00October 26, 2023|

William C. Weldon is Chairman of the Board of Johnson & Johnson. He assumed his current responsibilities in April, 2002. Previously Bill served as Worldwide Chairman, Pharmaceuticals Group, and a Vice Chairman of the Board of Directors. He was elected [...]

Christopher A. Viehbacher

2023-10-30T11:41:22-05:00October 26, 2023|

Mr. Christopher Viehbacher is president and CEO of Biogen, a multinational biotechology company. He is also a founding partner of Gurnet Point Capital, a Boston-based investment fund associated with the Bertarelli family with a $2 billion capital allocation. He is [...]

MaryLisabeth Rich

2023-10-30T13:03:25-05:00October 26, 2023|

MaryLisabeth Rich was appointed President of the CEO Roundtable on Cancer in January 2020. Prior to joining the CEO Roundtable on Cancer, MaryLisabeth served as Senior Vice President Development for the American Cancer Society Global Headquarters in Atlanta.  She earned recognition as a public [...]

William C. Louv, PhD

2023-10-30T13:03:10-05:00October 26, 2023|

Dr. Bill Louv was named Chief Executive Officer of the CEO Roundtable on Cancer and Project Data Sphere in March 2022 after serving as Interim CEO since January 1, 2022. He joined Project Data Sphere in March 2018 as President. Previously, he held key [...]

Belén Garijo, MD

2023-10-30T11:40:01-05:00October 26, 2023|

Belén Garijo is Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. She joined the company in 2011 as Chief Operating Officer of the Biopharma business, becoming President and CEO of Healthcare in 2015. In July 2020, Belén [...]

Peter WT Pisters, MD, MHCM

2023-10-30T11:36:10-05:00October 26, 2023|

Peter WT Pisters, M.D., took the helm as president of The University of Texas MD Anderson Cancer Center in 2017, and forged a new path forward to end cancer by transforming the culture of the nation’s top-ranked cancer center. With [...]

Marcelo C. Targino, MD, MPH

2023-11-03T13:40:36-05:00October 26, 2023|

Dr. Marcelo Targino is responsible for the Corporate Medical Team and the Executive Health program providing medical care and support for all executives and senior leaders across the enterprise at Johnson & Johnson. He is also responsible for staying ahead [...]

Scott White

2023-10-30T11:42:52-05:00October 26, 2023|

Scott White is Company Group Chairman, North America, at the Janssen Pharmaceutical Companies of Johnson & Johnson. A member of the Pharmaceuticals Group Operating Committee, he is responsible for leading Janssen’s efforts to transform the health of people in the [...]

Martin J. Murphy, DMedSc, PhD, FASCO

2023-10-30T11:45:26-05:00October 26, 2023|

Dr. Martin J. Murphy in 1999 accepted the challenge from President George H. W. Bush to help create and lead what would become the CEO Roundtable on Cancer as its Founding Chief Executive Officer, a role he which he served [...]

Robert A. Ingram – In Memoriam

2023-10-30T11:43:43-05:00October 26, 2023|

Robert "Bob" Ingram (1942-2023) was General Partner at Hatteras Venture Partners, a venture capital firm that invests in early stage life science companies. Prior to joining Hatteras, Mr. Ingram was Chief Executive Officer and Chairman of Glaxo/Wellcome. Mr. Ingram co-led the [...]

Go to Top